| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 08/05/2026 | ±3.2% | +5.6% | under-priced |
| 02/04/2026 | ±2.2% | -3.4% | under-priced |
| 11/06/2025 | ±3.3% | +1.7% | over-priced |
| 08/06/2025 | ±2.1% | -0.8% | over-priced |
| 11/07/2024 | ±2.8% | +10.6% | under-priced |
| 08/07/2024 | ±2.7% | +0.5% | over-priced |
| 02/08/2024 | ±2.1% | -4.4% | under-priced |
| 11/02/2023 | ±1.8% | -2.6% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2027 | $5.15 | $105.4B | $1.0B |
| Q4 FY2026 | $13.65 | $96.3B | $1.9B |
| Q3 FY2026 | $9.59 | $106.2B | $1.3B |
| Q2 FY2026 | $8.92 | $103.2B | $1.2B |
McKesson Corporation (MCK) reports in 121 days, with the next report estimated for 01/11/2027. Across the last 8 reports, options priced an average ±2.5% earnings move while the stock actually moved 3.7% on average — the market has been roughly fair on MCK's earnings risk. Fundamentals into the print: EPS down 17.6% year-over-year, revenue up 7.7%. QuantLogix's live 5-factor engine currently reads MCK as a neutral at 47/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →